Campbell & Co Investment Adviser’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Campbell & Co Investment Adviser's AMGN Position: Q2 2026 in Review
Campbell & Co Investment Adviser increased its Amgen (AMGN) stake by 30% in Q2 2026, buying an estimated $1.46M and bringing the position to 18,379 shares worth $6.66M. The position accounts for 0.35% of the portfolio, ranked #35.
Campbell & Co Investment Adviser first reported a position in AMGN in Q4 2014 and has held it in 15 quarters since. 3,163 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Campbell & Co Investment Adviser held 18,379 shares of Amgen worth $6.66M as of Q2 2026.
- Campbell & Co Investment Adviser bought 4,269 Amgen shares in Q2 2026, an estimated $1.46M.
- Amgen made up 0.35% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #35 holding.
- Campbell & Co Investment Adviser first reported a position in Amgen in Q4 2014 and has held it in 15 quarters since.
- 3,163 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.